Cardiff Oncology Inc. (CRDF)
NASDAQ · Healthcare
Cardiff Oncology Inc. Revenue 2011–2025
Cardiff Oncology Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cardiff Oncology Inc. revenue for the quarter ending March 31, 2026 was 41000, a 62.39% decrease year-over-year.
- Cardiff Oncology Inc. revenue for the twelve months ending March 31, 2026 was 391000, a 41.99% decrease year-over-year.
- Cardiff Oncology Inc. annual revenue for 2025 was 593000, a 13.18% decrease from 2024.
- Cardiff Oncology Inc. annual revenue for 2024 was 683000, a 39.96% increase from 2023.
- Cardiff Oncology Inc. annual revenue for 2023 was 488000, a 26.42% increase from 2022.
- Cardiff Oncology Inc. annual revenue for 2022 was 386000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cardiff Oncology Inc. Revenue — FAQ
Cardiff Oncology Inc. (CRDF) revenue over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Cardiff Oncology Inc.'s revenue?
Cardiff Oncology Inc. (CRDF) reported revenue of $593,000 for fiscal 2025.
Where can I see CRDF's revenue history?
The chart and table above show Cardiff Oncology Inc.'s revenue by year and by quarter, including the growth rate.